Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submission of Medical Device Registration and Listing, 13801-13802 [2016-05744]

Download as PDF Federal Register / Vol. 81, No. 50 / Tuesday, March 15, 2016 / Notices 0910–0338; the collections of information in 21 CFR 606.65, 606.100, 606.120, 606.121, 606.122, and have been approved under OMB control number 0910–0116; and the collections of information in 21 CFR part 607 have been approved under OMB control number 0910–0052. To ensure that comments on information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB (see ADDRESSES). All comments should be identified with the title of the information collection. In compliance with the PRA (44 U.S.C. 3407(d)), the Agency has submitted the information collection provisions of this document to OMB for review. These requirements will not be effective until FDA obtains OMB approval. FDA will publish a notice concerning OMB approval of these requirements in the Federal Register. III. Electronic Access Persons with access to the Internet may obtain the draft guidance at either https://www.fda.gov/BiologicsBlood Vaccines/GuidanceCompliance RegulatoryInformation/Guidances/ default.htm or https:// www.regulations.gov. Dated: March 9, 2016. Leslie Kux, Associate Commissioner for Policy. BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–3815] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submission of Medical Device Registration and Listing Food and Drug Administration, HHS. asabaliauskas on DSK3SPTVN1PROD with NOTICES ACTION: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or emailed to oira_ submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–0625. Also include the FDA docket number found in brackets in the heading of this document. ADDRESSES: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. SUPPLEMENTARY INFORMATION: Electronic Submission of Medical Device Registration and Listing—21 CFR Part 807, Subparts A Through D; OMB Control Number 0910–0625— Extension [FR Doc. 2016–05718 Filed 3–14–16; 8:45 am] AGENCY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by April 14, 2016. SUMMARY: Notice. Under section 510 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360) and part 807, subparts A through D (21 CFR part 807, subparts A through D), medical device establishment owners and operators are required to electronically submit establishment registration and device listing information. Complete and accurate registration and listing information is necessary to accomplish a number of statutory and regulatory objectives, such as: (1) Identification of establishments producing marketed medical devices, (2) identification of establishments producing a specific device when that 13801 device is in short supply or is needed for national emergency, (3) facilitation of recalls for devices marketed by owners and operators of device establishments, (4) identification and cataloguing of marketed devices, (5) administering postmarketing surveillance programs for devices, (6) identification of devices marketed in violation of the law, (7) identification and control of devices imported into the country from foreign establishments, (8) and scheduling and planning inspections of registered establishments under section 704 of the FD&C Act (21 U.S.C. 374). Respondents to this information collection are owners or operators of establishments that engage in the manufacturing, preparation, propagation, compounding, or processing of a device or devices, who must register their establishments and submit listing information for each of their devices in commercial distribution. Notwithstanding certain exceptions, foreign device establishments that manufacture, prepare, propagate, compound, or process a device that is imported or offered for import into the United States must also comply with the registration and listing requirements. The number of respondents is based on data from the FDA Unified Registration and Listing System. Burden estimates are based on recent experience with the existing medical device registration and listing program, electronic system operating experience, and the economic analysis for the final rule entitled ‘‘Implementation of Device Registration and Listing Requirements Enacted in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, the Medical Device User Fee and Modernization Act of 2002, and Title II of the Food and Drug Administration Amendments Act of 2007.’’ In the Federal Register of October 27, 2015 (80 FR 65779), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 21 CFR Section FDA Form No. 807.20(a)(5) 2—Submittal of manufacturer information by initial importers. 807.20(a)(5) 3—Submittal of manufacturer information by initial importers. VerDate Sep<11>2014 17:40 Mar 14, 2016 Jkt 238001 Number of respondents Number of responses per respondent Average burden per response Total annual responses Total hours 3673 1 8,594 1.75 ................ 15,040 3673 PO 00000 8,594 8,594 3 25,782 .1 .................... (6 minutes) ..... 2,578 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\15MRN1.SGM 15MRN1 13802 Federal Register / Vol. 81, No. 50 / Tuesday, March 15, 2016 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 21 CFR Section FDA Form No. 807.21(a) 3—Creation of electronic system account. 807.21(b) 2—Annual request for waiver from electronic registration and listing. 807.21(b) 3—Initial request for waiver from electronic registration and listing. 807.22(a) 3—Initial registration and listing Number of responses per respondent Number of respondents Average burden per response Total annual responses 3673 3,559 1 3,559 ........................ 14 1 ........................ 4 3673 807.22(b)(1) 3—Annual registration ......... 807.22(b)(2) 3—Other updates of registration. 807.22(b)(3) 3—Annual update of listing information. 807.26(e) 3—Labeling and advertisement submitted at FDA request. 807.34(a) 2—Initial registration and listing when electronic filing waiver granted. 807.34(a) 3—Annual registration and listing when electronic filing waiver granted. 807.40(b)(2) 3—Annual update of U.S. agent information. 807.40(b)(3) 3—U.S. agent responses to FDA requests for information. 807.41(a) 3—Identification of initial importers by foreign establishments. 807.41(b) 3—Identification of other parties that facilitate import by foreign establishments. Total hours 1,780 14 .5 .................... (30 minutes) ... 1 ..................... 1 4 1 ..................... 4 3,539 1 3,539 1,770 3673 20,355 1 20,355 3673 4,176 1 4,176 3673 19,875 1 19,875 .5 .................... (30 minutes) ... .75 .................. (45 minutes) ... .5 .................... (30 minutes) ... 1 ..................... ........................ 71 1 71 1 ..................... 71 ........................ 14 1 14 1 ..................... 14 ........................ 4 1 4 1 ..................... 4 3673 1,615 1 1,615 808 3673 1,535 1 1,535 3673 10,329 1 10,329 3673 10,329 1 10,329 .5 .................... (30 minutes) ... .25 .................. (15 minutes) ... .5 .................... (30 minutes) ... .5 .................... (30 minutes) ... Total one-time burden ...................... ........................ ........................ ........................ ........................ ........................ 15,068 Total recurring burden ...................... ........................ ........................ ........................ ........................ ........................ 54,958 14 15,266 2,088 19,875 384 5,165 5,165 1 There are no capital costs or operating and maintenance costs associated with this collection of information. burden. 3 Recurring burden. 2 One-time TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1 Number of recordkeepers 21 CFR Section Number of records per recordkeeper Total annual records 807.25(d) 2—List of officers, directors and partners ............ 23,806 1 23,806 807.26 2—Labeling and advertisements available for review. 11,746 4 46,984 Total .............................................................................. ........................ ........................ ........................ 1 There Average burden per recordkeeping .25 .................. (30 minutes) ... .5 .................... (30 minutes) ... ........................ are no capital costs or operating and maintenance costs associated with this collection of information. burden. 2 Recurring Dated: March 9, 2016. Leslie Kux, Associate Commissioner for Policy. asabaliauskas on DSK3SPTVN1PROD with NOTICES [FR Doc. 2016–05744 Filed 3–14–16; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 17:40 Mar 14, 2016 Jkt 238001 PO 00000 Frm 00032 Fmt 4703 Sfmt 9990 E:\FR\FM\15MRN1.SGM 15MRN1 Total hours 5,952 23,492 29,444

Agencies

[Federal Register Volume 81, Number 50 (Tuesday, March 15, 2016)]
[Notices]
[Pages 13801-13802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05744]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-3815]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Electronic Submission 
of Medical Device Registration and Listing

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by April 
14, 2016.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be faxed to the Office 
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, 
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All 
comments should be identified with the OMB control number 0910-0625. 
Also include the FDA docket number found in brackets in the heading of 
this document.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Electronic Submission of Medical Device Registration and Listing--21 
CFR Part 807, Subparts A Through D; OMB Control Number 0910-0625--
Extension

    Under section 510 of the Federal Food, Drug, and Cosmetic Act (the 
FD&C Act) (21 U.S.C. 360) and part 807, subparts A through D (21 CFR 
part 807, subparts A through D), medical device establishment owners 
and operators are required to electronically submit establishment 
registration and device listing information.
    Complete and accurate registration and listing information is 
necessary to accomplish a number of statutory and regulatory 
objectives, such as: (1) Identification of establishments producing 
marketed medical devices, (2) identification of establishments 
producing a specific device when that device is in short supply or is 
needed for national emergency, (3) facilitation of recalls for devices 
marketed by owners and operators of device establishments, (4) 
identification and cataloguing of marketed devices, (5) administering 
postmarketing surveillance programs for devices, (6) identification of 
devices marketed in violation of the law, (7) identification and 
control of devices imported into the country from foreign 
establishments, (8) and scheduling and planning inspections of 
registered establishments under section 704 of the FD&C Act (21 U.S.C. 
374).
    Respondents to this information collection are owners or operators 
of establishments that engage in the manufacturing, preparation, 
propagation, compounding, or processing of a device or devices, who 
must register their establishments and submit listing information for 
each of their devices in commercial distribution. Notwithstanding 
certain exceptions, foreign device establishments that manufacture, 
prepare, propagate, compound, or process a device that is imported or 
offered for import into the United States must also comply with the 
registration and listing requirements. The number of respondents is 
based on data from the FDA Unified Registration and Listing System.
    Burden estimates are based on recent experience with the existing 
medical device registration and listing program, electronic system 
operating experience, and the economic analysis for the final rule 
entitled ``Implementation of Device Registration and Listing 
Requirements Enacted in the Public Health Security and Bioterrorism 
Preparedness and Response Act of 2002, the Medical Device User Fee and 
Modernization Act of 2002, and Title II of the Food and Drug 
Administration Amendments Act of 2007.''
    In the Federal Register of October 27, 2015 (80 FR 65779), FDA 
published a 60-day notice requesting public comment on the proposed 
collection of information. No comments were received.
    FDA estimates the burden of this collection of information as 
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                             Number of
             21 CFR Section                FDA Form No.      Number of     responses per   Total annual     Average burden per response     Total hours
                                                            respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
807.20(a)(5) \2\--Submittal of                      3673           8,594               1           8,594  1.75..........................          15,040
 manufacturer information by initial
 importers.
807.20(a)(5) \3\--Submittal of                      3673           8,594               3          25,782  .1............................           2,578
 manufacturer information by initial                                                                      (6 minutes)...................
 importers.

[[Page 13802]]

 
807.21(a) \3\--Creation of electronic               3673           3,559               1           3,559  .5............................           1,780
 system account.                                                                                          (30 minutes)..................
807.21(b) \2\--Annual request for waiver  ..............              14               1              14  1.............................              14
 from electronic registration and
 listing.
807.21(b) \3\--Initial request for        ..............               4               1               4  1.............................               4
 waiver from electronic registration and
 listing.
807.22(a) \3\--Initial registration and             3673           3,539               1           3,539  .5............................           1,770
 listing.                                                                                                 (30 minutes)..................
807.22(b)(1) \3\--Annual registration...            3673          20,355               1          20,355  .75...........................          15,266
                                                                                                          (45 minutes)..................
807.22(b)(2) \3\--Other updates of                  3673           4,176               1           4,176  .5............................           2,088
 registration.                                                                                            (30 minutes)..................
807.22(b)(3) \3\--Annual update of                  3673          19,875               1          19,875  1.............................          19,875
 listing information.
807.26(e) \3\--Labeling and               ..............              71               1              71  1.............................              71
 advertisement submitted at FDA request.
807.34(a) \2\--Initial registration and   ..............              14               1              14  1.............................              14
 listing when electronic filing waiver
 granted.
807.34(a) \3\--Annual registration and    ..............               4               1               4  1.............................               4
 listing when electronic filing waiver
 granted.
807.40(b)(2) \3\--Annual update of U.S.             3673           1,615               1           1,615  .5............................             808
 agent information.                                                                                       (30 minutes)..................
807.40(b)(3) \3\--U.S. agent responses              3673           1,535               1           1,535  .25...........................             384
 to FDA requests for information.                                                                         (15 minutes)..................
807.41(a) \3\--Identification of initial            3673          10,329               1          10,329  .5............................           5,165
 importers by foreign establishments.                                                                     (30 minutes)..................
807.41(b) \3\--Identification of other              3673          10,329               1          10,329  .5............................           5,165
 parties that facilitate import by                                                                        (30 minutes)..................
 foreign establishments.
                                         ---------------------------------------------------------------------------------------------------------------
    Total one-time burden...............  ..............  ..............  ..............  ..............  ..............................          15,068
                                         ---------------------------------------------------------------------------------------------------------------
    Total recurring burden..............  ..............  ..............  ..............  ..............  ..............................          54,958
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ One-time burden.
\3\ Recurring burden.


                               Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                 Number of
       21 CFR Section            Number of      records per    Total annual   Average burden per    Total hours
                               recordkeepers   recordkeeper       records        recordkeeping
----------------------------------------------------------------------------------------------------------------
807.25(d) \2\--List of                23,806               1          23,806  .25...............           5,952
 officers, directors and                                                      (30 minutes)......
 partners.
807.26 \2\--Labeling and              11,746               4          46,984  .5................          23,492
 advertisements available                                                     (30 minutes)......
 for review.
                             -----------------------------------------------------------------------------------
    Total...................  ..............  ..............  ..............  ..................          29,444
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
\2\ Recurring burden.


    Dated: March 9, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-05744 Filed 3-14-16; 8:45 am]
BILLING CODE 4164-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.